InspireMD Eyes US Launch Amid Revenue Growth
InspireMD reports revenue growth in Q2 2024 and plans to launch CGuard Prime in the US by 2025, despite current ...
- Latest
- Trending
InspireMD reports revenue growth in Q2 2024 and plans to launch CGuard Prime in the US by 2025, despite current ...
Duolingo stock down 29% but AI advancements signal long-term growth. Explore why it's a prime investment opportunity.
Rigetti Computing advances 84-qubit tech amid mixed Q2 results.
Pagaya exceeds Q2 earnings, boosts 2024 outlook, citing strong fee revenue growth, strategic alliances, and operational efficiencies.
Roivant reports strong clinical progress, with significant Phase 3 study completions, revenue growth, and financial strength.
Organogenesis exceeds Q2 revenue expectations at $130.2M, driven by robust sales and strategic growth plans.
Diodes Inc. outperformed Q2 expectations and eyes growth in AI and automotive sectors, projecting strong Q3 revenue.
Personalis sees 35% Q2 revenue growth, lifts full-year outlook to $79-$81M.
Bumble sees 14% rise in users, revenue up 3% to $269M. Strategic shifts focus on engagement, user experience, and Geneva ...
Beyond Meat sees an 8.8% drop in Q2 revenues but boosts margins and reduces expenses. Forecasts positive outlook for 2024.
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.